In February, the company announced an agreement to acquire exclusive rights to the Xvision augmented reality (AR) navigation, adding it to the VB Spine visualization portfolio.
Augmedics developed its Xvision Spine System to use AR to give surgeons “X-ray vision” during surgery. The system superimposes critical data onto the surgical field, allowing surgeons to visualize patient anatomy through the skin and tissue.
Xvision Spine System offers an aid for precisely locating anatomical structures in either open, minimally invasive or percutaneous spine procedures. Augmedics received FDA clearance for a next-generation AR headset for the platform in November 2025. The system holds FDA clearance along with its software. Clearance covers precisely locating anatomical structures either open, minimally invasive or percutaneous spine procedures.
This deal marks the latest addition to the VB Spine portfolio. The company also acquired AI-powered surgical visualization technology from Robotron Surgical in January. It also bought Stryker’s spinal implants business last year, then added a Stryker manufacturing facility in France.
“We are thrilled at how quickly this transaction completed. It is a testament to how critical the xvision Spine System platform is to the future of spine care and demonstrates our desire to realize the potential of augmented reality. We are moving to operationalize the business and are grateful for this opportunity,” said Marc Viscogliosi, co-CEO of VB Spine, speaking on behalf of his brothers, Anthony and John Viscogliosi.
